Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis

被引：0
|
作者：
Kenji Omae
Tsunenori Kondo
Takafumi Kennoki
Toshio Takagi
Junpei Iizuka
Hirohito Kobayashi
Yasunobu Hashimoto
Kazunari Tanabe
机构：
[1] Tokyo Women’s Medical University,Department of Urology
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Renal cancer; End-stage renal disease; Prognosis; Survival; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 132
页数：6
相关论文
共 50 条
  • [1] Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis
    Omae, Kenji
    Kondo, Tsunenori
    Kennoki, Takafumi
    Takagi, Toshio
    Iizuka, Junpei
    Kobayashi, Hirohito
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) : 126 - 132
  • [2] Efficacy and safety of temsirolimus in Japanese patients with metastatic renal cell carcinoma on hemodialysis
    Miyake, Hideaki
    Harada, Ken-ichi
    Kusuda, Yuji
    Fujisawa, Masato
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 1054 - 1059
  • [3] Efficacy and safety of temsirolimus in Japanese patients with metastatic renal cell carcinoma on hemodialysis
    Hideaki Miyake
    Ken-ichi Harada
    Yuji Kusuda
    Masato Fujisawa
    [J]. International Journal of Clinical Oncology, 2013, 18 : 1054 - 1059
  • [4] Efficacy and safety of sunitinib in patients with metastatic renal cell carcinoma on hemodialysis.
    Casper, J.
    Goebel, D.
    Gruenwald, V.
    Floercken, A.
    Mueller, D.
    Toussaint, K.
    Metzner, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Feasibility and safety of administration of sorafenib in chronic hemodialysis patients with metastatic renal cell carcinoma: Clinical results and pharmacokinetics in a single Japanese center
    Kennoki, T.
    Kondo, T.
    Hashimoto, Y.
    Kimata, N.
    Murakami, J.
    Ishimori, I.
    Iizuka, J.
    Takiga, T.
    Nakazawa, H.
    Tanabe, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Safety and Efficacy of Sorafenib in Renal Cell Carcinoma
    Edeline, Julien
    Vauleon, Elodie
    Rioux-Leclercq, Nathalie
    Perrin, Christophe
    Vigneau, Cecile
    Bensalah, Karim
    Laguerre, Brigitte
    [J]. CANCER GROWTH AND METASTASIS, 2012, 5 : 35 - 47
  • [7] Relationship of Pathological Factors To Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Tsuzuki, Toyonori
    Araki, Hidemori
    Kimura, Tohru
    Tanaka, Kuniaki
    Yamada, Shin
    Sassa, Naoto
    Yoshino, Yasushi
    Hattori, Ryohei
    Gotoh, Momokazu
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 263A - 264A
  • [8] Relationship of Pathological Factors To Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Tsuzuki, Toyonori
    Araki, Hidemori
    Kimura, Tohru
    Tanaka, Kuniaki
    Yamada, Shin
    Sassa, Naoto
    Yoshino, Yasushi
    Hattori, Ryohei
    Gotoh, Momokam
    [J]. MODERN PATHOLOGY, 2015, 28 : 263A - 264A
  • [9] Relationship of Pathologic Factors to Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Araki, Hidemori
    Tsuzuki, Toyonori
    Kimura, Tohru
    Tanaka, Kuniaki
    Yamada, Shin
    Sassa, Naoto
    Yoshino, Yasushi
    Hattori, Ryohei
    Gotoh, Momokazu
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (04) : 492 - 499
  • [10] A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety
    Uemura, Hirotsugu
    Shinohara, Nobuo
    Yuasa, Takeshi
    Tomita, Yoshihiko
    Fujimoto, Hiroyuki
    Niwakawa, Masashi
    Mugiya, Soichi
    Miki, Tsuneharu
    Nonomura, Norio
    Takahashi, Masayuki
    Hasegawa, Yoshihiro
    Agata, Naoki
    Houk, Brett
    Naito, Seiji
    Akaza, Hideyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (03) : 194 - 202
12345